Jiangang Liu

Jiangang Liu

Auto-generated profile, based on publicly available information

Jiangang Liu

Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
Our previous study illustrated that nuclear factor IX (NFIX) promotes glioblastoma (GBM) progression by inducing migration and proliferation of GBM cells. However, the underlying mechanism of how NFIX regulates GBM cell proliferation remains obscure. In this study, we uncovered that Go-Ichi-Ni-San 1 (GINS1) is upregulated and positively correlated with NFIX in human GBM specimen. NFIX silencing downregulates the expression of GINS1, which is pivotal for cell-cycle progression and proliferation of GBM cells. Replenishment of GINS1 largely rescues the NFIX-null effect on GBM cell proliferation. Mechanistic investigation revealed that NFIX transcriptionally actives GINS1 expression by directly binding to promoter region (-1779 to -1793bp) of the GINS1 gene. Furthermore, knockdown of NFIX sensitizes GBM cells to DNA damage-inducing agents including doxorubicin and temozolomide, in a GINS1-dependent manner. Implications: Our study highlights that targeting NFIX–GINS1 axis could be a novel and potential therapeutic approach for GBM treatment.

3 April 2023
Verified
Other
Open access
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
S1. Full images of immunoblotting. S2. NFIX knockdown has no effect on p53 and p21 expression. S3. Knockdown of GINS1 by shRNAs in U87 cells. S4. Knockdown of GINS1 represses proliferation of GL261 cells S5. GINS1 rescues the delayed growth of NFIX-null GL261 tumor. S6. NFIX directly up-regulated GINS1 gene by occupying its promoter

3 April 2023
Verified
Other
Open access
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
Table S1. Primer sequences for mRNA expression analysis. Table S2. Sequences of shRNA. Table S3. Antibodies for immunoblotting.

27 November 2025
Verified
Other
Open access
PDF file
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
S1. Full images of immunoblotting. S2. NFIX knockdown has no effect on p53 and p21 expression. S3. Knockdown of GINS1 by shRNAs in U87 cells. S4. Knockdown of GINS1 represses proliferation of GL261 cells S5. GINS1 rescues the delayed growth of NFIX-null GL261 tumor. S6. NFIX directly up-regulated GINS1 gene by occupying its promoter

3 April 2023
Verified
Other
Open access
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
Our previous study illustrated that nuclear factor IX (NFIX) promotes glioblastoma (GBM) progression by inducing migration and proliferation of GBM cells. However, the underlying mechanism of how NFIX regulates GBM cell proliferation remains obscure. In this study, we uncovered that Go-Ichi-Ni-San 1 (GINS1) is upregulated and positively correlated with NFIX in human GBM specimen. NFIX silencing downregulates the expression of GINS1, which is pivotal for cell-cycle progression and proliferation of GBM cells. Replenishment of GINS1 largely rescues the NFIX-null effect on GBM cell proliferation. Mechanistic investigation revealed that NFIX transcriptionally actives GINS1 expression by directly binding to promoter region (-1779 to -1793bp) of the GINS1 gene. Furthermore, knockdown of NFIX sensitizes GBM cells to DNA damage-inducing agents including doxorubicin and temozolomide, in a GINS1-dependent manner.Implications:Our study highlights that targeting NFIX–GINS1 axis could be a novel and potential therapeutic approach for GBM treatment.

3 April 2023
Verified
Other
Open access
RGRuixiang Ge
Ruixiang Ge
CWChenci Wang
Chenci Wang
JLJiangang Liu
Jiangang Liu
HJHaibo Jiang
Haibo Jiang
XJXiaoChun Jiang
XiaoChun Jiang
ZLZhuohao Liu
Zhuohao Liu
S1. Full images of immunoblotting. S2. NFIX knockdown has no effect on p53 and p21 expression. S3. Knockdown of GINS1 by shRNAs in U87 cells. S4. Knockdown of GINS1 represses proliferation of GL261 cells S5. GINS1 rescues the delayed growth of NFIX-null GL261 tumor. S6. NFIX directly up-regulated GINS1 gene by occupying its promoter